HeartFlow

HeartFlow develops artificial intelligence software that analyzes coronary CT angiography images to assess coronary artery disease without invasive procedures. Founded in 2011, the company was created by researchers with expertise in computational imaging, fluid dynamics, and cardiovascular medicine. Headquartered in Redwood City, California, HeartFlow developed FFR-CT technology that uses advanced algorithms to predict blood flow in coronary arteries, helping cardiologists and interventional radiologists determine which patients require intervention. The company went public on NASDAQ in 2021 (ticker TREE) and now serves a global market of physicians seeking to improve diagnostic accuracy and clinical decision-making in coronary artery disease assessment.